172 related articles for article (PubMed ID: 32847839)
21. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
22. Angiosarcoma of the breast.
Vorburger SA; Xing Y; Hunt KK; Lakin GE; Benjamin RS; Feig BW; Pisters PW; Ballo MT; Chen L; Trent J; Burgess M; Patel S; Pollock RE; Cormier JN
Cancer; 2005 Dec; 104(12):2682-8. PubMed ID: 16288486
[TBL] [Abstract][Full Text] [Related]
23. SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
Davis EJ; Zhao L; Lucas DR; Schuetze SM; Baker LH; Zalupski MM; Thomas D; Chugh R
BMC Cancer; 2016 Aug; 16():663. PubMed ID: 27544129
[TBL] [Abstract][Full Text] [Related]
24. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.
Grobmyer SR; Maki RG; Demetri GD; Mazumdar M; Riedel E; Brennan MF; Singer S
Ann Oncol; 2004 Nov; 15(11):1667-72. PubMed ID: 15520069
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous Angiosarcoma: Clinical and Pathology Study of 16 Cases.
Requena C; Sendra E; Llombart B; Sanmartín O; Guillén C; Lavernia J; Traves V; Cruz J
Actas Dermosifiliogr; 2017 Jun; 108(5):457-465. PubMed ID: 28318524
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll PJ; Reichardt P; Le Cesne A; Bonvalot S; Azzarelli A; Hoekstra HJ; Leahy M; Van Coevorden F; Verweij J; Hogendoorn PC; Ouali M; Marreaud S; Bramwell VH; Hohenberger P;
Lancet Oncol; 2012 Oct; 13(10):1045-54. PubMed ID: 22954508
[TBL] [Abstract][Full Text] [Related]
27. Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers.
Marchal C; Weber B; de Lafontan B; Resbeut M; Mignotte H; du Chatelard PP; Cutuli B; Reme-Saumon M; Broussier-Leroux A; Chaplain G; Lesaunier F; Dilhuydy JM; Lagrange JL
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):113-9. PubMed ID: 10219803
[TBL] [Abstract][Full Text] [Related]
28. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin, paclitaxel, and cisplatin based chemotherapy for the treatment of angiosarcoma: Two case reports.
Lewcun JA; Pameijer C; Kass R; Cream L; Hershock D; Brooks AJ; Dodge DG
Int J Surg Case Rep; 2020; 68():83-87. PubMed ID: 32120283
[TBL] [Abstract][Full Text] [Related]
30. Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma.
McClelland S; Hatfield J; Degnin C; Chen Y; Mitin T
Breast Cancer Res Treat; 2019 Jun; 175(2):409-418. PubMed ID: 30820717
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
32. Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.
Shon W; Jenkins SM; Ross DT; Seitz RS; Beck RA; Ring BZ; Okuno SH; Gibson LE; Folpe AL
J Cutan Pathol; 2011 Dec; 38(12):961-6. PubMed ID: 22050093
[TBL] [Abstract][Full Text] [Related]
33. Combining limb-sparing surgery with radiation therapy in high-grade soft tissue sarcoma of extremities - Is it effective?
Müller DA; Beltrami G; Scoccianti G; Frenos F; Capanna R
Eur J Surg Oncol; 2016 Jul; 42(7):1057-63. PubMed ID: 26924784
[TBL] [Abstract][Full Text] [Related]
34. Primary and secondary breast angiosarcoma: single center report and a meta-analysis.
Abdou Y; Elkhanany A; Attwood K; Ji W; Takabe K; Opyrchal M
Breast Cancer Res Treat; 2019 Dec; 178(3):523-533. PubMed ID: 31522347
[TBL] [Abstract][Full Text] [Related]
35. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Wendtner CM; Abdel-Rahman S; Krych M; Baumert J; Lindner LH; Baur A; Hiddemann W; Issels RD
J Clin Oncol; 2002 Jul; 20(14):3156-64. PubMed ID: 12118030
[TBL] [Abstract][Full Text] [Related]
36. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
37. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases.
Fayette J; Martin E; Piperno-Neumann S; Le Cesne A; Robert C; Bonvalot S; Ranchère D; Pouillart P; Coindre JM; Blay JY
Ann Oncol; 2007 Dec; 18(12):2030-6. PubMed ID: 17974557
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
[TBL] [Abstract][Full Text] [Related]
39. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
40. Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution.
Florou V; Rosenberg AE; Wieder E; Komanduri KV; Kolonias D; Uduman M; Castle JC; Buell JS; Trent JC; Wilky BA
J Immunother Cancer; 2019 Aug; 7(1):213. PubMed ID: 31395100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
